| abstract |
The compounds having the formulae (I), (II), (III), (IV), (V), in which R is (VI), consist of a pattern derived from beta-blockers and an imidazolidine pattern possessing alpha-antagonistic properties. These compounds, which are new, therefore have the antagonistic properties of the beta-adreno-receptors and can consequently be used to lower the intraorbital pressure, in particular in glaucoma cases. |